Resultados de la búsqueda 261-270 of 4969 for Two-phase
This phase III trial compares the effect of usual ... The Patient Group 2 ... The purpose of this study is to determine the maximum tolerated dose (MTD) and ...
The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 ... stage III-IV squamous cell head and neck cancer.
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...
This Phase 3 study is designed to evaluate the ... Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase ... 2 prior lines of therapy. The primary objectives ...
Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase ... This Phase 3 study is designed to ... 2 prior lines of therapy. The primary objectives ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL). Rochester, Minn. The purpose of ths study is to find out more about ...
... Phase 1/2 study in a selected cohort of patient with LM. A Study to Evaluate MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation.
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?